TEKTURNA NEWS HIGHLIGHTS Media Articles Related to Tekturna (Aliskiren)
Rasilez®, First-in-class Direct Renin Inhibitor, Provides Greater Reduction In High Blood Pressure Than ACE Inhibitor Ramipril Source: Hypertension News From Medical News Today [2008.11.15]
Rasilez HCT®, Single-pill Combination Of Rasilez® And Diuretic, Receives Swiss Approval For The Treatment Of High Blood Pressure Source: Hypertension News From Medical News Today [2008.11.06]
Hypertension Develops Early, Silently, In African-American Men Source: Hypertension News From Medical News Today [2008.11.18]
FREEDOM-C Trial Of Oral Treprostinil In Pulmonary Arterial Hypertension Fails To Meet Primary Endpoint Source: Hypertension News From Medical News Today [2008.11.18]
Hypertension In Europe: A Worrying Scenario Source: Hypertension News From Medical News Today [2008.11.12]
Published Studies Related to Tekturna (Aliskiren)
Aliskiren combined with losartan in type 2 diabetes and nephropathy. [2008.06.05]
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. [2008.03]
Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension. [2007.12]
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure. [2007.11]
Hormonal and hemodynamic effects of aliskiren and valsartan and their combination in sodium-replete normotensive individuals. [2007.09]
Clinical Trials Related to Tekturna (Aliskiren)
Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects. [Completed]
Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects. [Completed]
A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients [Completed]
Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension [Recruiting]
SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension [Active, not recruiting]
|